CJCADR’s research facilities, within the Queensland Brain Institute, are world-class, with access to cutting-edge imaging technologies, super-resolution microscopy and research super-computing, as well as molecular and cellular technologies in gene-editing, biochemistry and histology.

CJCADR’s research spans:

  • fundamental research to understand dementia disease processes at a molecular, cellular and tissue level;
  • translational research to develop discoveries toward viable products and therapies;
  • clinical studies of diagnostic tools and interventions to improve the health of people living with, and those at risk of developing, dementia.
  • engagement with clinicians and the care sector to ensure strong and reciprocal links; and,
  • building Australia’s dementia research capacity through the mentoring of early career researchers, and PhD and master’s students.

CJCADR draws together 12 of QBI’s research groups, bringing broad expertise in brain research to the challenges presented by dementia.

 
  • Anggono

    Synaptic neurobiology
  • Bartlett

    Neurogenic regulation of cognition
  • Coulson

    Neurotrophins in Alzheimer's disease
  • Götz

    Basic neuroscience and ageing dementia
  • Hilliard

    Molecular and cellular neurobiology
  • Meunier

    Single molecule neuroscience 
  • Nestor

    Cognitive neurology
  • Padmanabhan

    Molecular and systems medicine
  • Robinson 

    Cognitive and clinical neuroscience
  • Walker A.

    Neurodegeneration pathobiology
  • Walker T.

    Synaptic neurobiology
  • Zuryn

    Epigenetics and mitochondrial biology​​